• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP结合是否负责多药转运蛋白ABCG2启动药物转运?

Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?

作者信息

McDevitt Christopher A, Crowley Emily, Hobbs Gemma, Starr Kate J, Kerr Ian D, Callaghan Richard

机构信息

Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK.

出版信息

FEBS J. 2008 Sep;275(17):4354-62. doi: 10.1111/j.1742-4658.2008.06578.x. Epub 2008 Jul 24.

DOI:10.1111/j.1742-4658.2008.06578.x
PMID:18657189
Abstract

ABCG2 confers resistance to cancer cells by mediating the ATP-dependent outward efflux of chemotherapeutic compounds. Recent studies have indicated that the protein contains a number of interconnected drug binding sites. The present investigation examines the coupling of drug binding to ATP hydrolysis. Initial drug binding to the protein requires a high-affinity interaction with the drug binding site, followed by transition and reorientation to the low-affinity state to enable dissociation at the extracellular face. [3H]Daunomycin binding to the ABCG2 R482G isoform was examined in the nucleotide-bound and post-hydrolytic conformations. Binding of [3H]daunomycin was displaced by ATP analogues, indicating transition to a low-affinity conformation prior to hydrolysis. The low-affinity state was observed to be retained immediately post-hydrolysis. Therefore, the dissociation of phosphate and/or ADP is likely to be responsible for resetting of the transporter. The data indicate that, like ABCB1 and ABCC1, the 'power stroke' for translocation in ABCG2 R482G is the binding of nucleotide.

摘要

ABCG2 通过介导化疗化合物的 ATP 依赖性外向流出赋予癌细胞耐药性。最近的研究表明,该蛋白包含多个相互连接的药物结合位点。本研究考察了药物结合与 ATP 水解的偶联。药物与蛋白的初始结合需要与药物结合位点进行高亲和力相互作用,随后转变并重新定向至低亲和力状态,以便在细胞外表面解离。在核苷酸结合构象和水解后构象中检测了 [3H]柔红霉素与 ABCG2 R482G 异构体的结合。ATP 类似物可取代 [3H]柔红霉素的结合,表明在水解之前转变为低亲和力构象。观察到在水解后立即保留低亲和力状态。因此,磷酸盐和/或 ADP 的解离可能负责转运体的重置。数据表明,与 ABCB1 和 ABCC1 一样,ABCG2 R482G 转运的“动力冲程”是核苷酸的结合。

相似文献

1
Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?ATP结合是否负责多药转运蛋白ABCG2启动药物转运?
FEBS J. 2008 Sep;275(17):4354-62. doi: 10.1111/j.1742-4658.2008.06578.x. Epub 2008 Jul 24.
2
Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.ABCG2转运蛋白R482G亚型上的多个药物结合位点。
Br J Pharmacol. 2006 Nov;149(5):506-15. doi: 10.1038/sj.bjp.0706904. Epub 2006 Sep 18.
3
Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.人ABCG2多药转运蛋白的药物转运、ATP水解及核苷酸捕获特性。点突变对底物特异性的调控。
J Biol Chem. 2002 Dec 13;277(50):47980-90. doi: 10.1074/jbc.M207857200. Epub 2002 Oct 8.
4
Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.ABCG2多药转运蛋白的功能依赖性构象变化改变了其与细胞表面单克隆抗体的相互作用。
J Biol Chem. 2005 Feb 11;280(6):4219-27. doi: 10.1074/jbc.M411338200. Epub 2004 Nov 22.
5
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478.表皮生长因子受体酪氨酸激酶抑制剂AG1478对ABCB1和ABCG2功能的抑制作用
Biochem Pharmacol. 2009 Mar 1;77(5):781-93. doi: 10.1016/j.bcp.2008.11.007. Epub 2008 Nov 18.
6
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.舒尼替尼(索坦,SU11248)是一种小分子受体酪氨酸激酶抑制剂,可阻断ATP结合盒(ABC)转运蛋白P-糖蛋白(ABCB1)和ABCG2的功能。
Drug Metab Dispos. 2009 Feb;37(2):359-65. doi: 10.1124/dmd.108.024612. Epub 2008 Oct 29.
7
The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.乳腺癌耐药蛋白ABCG2的连接区对于ATP依赖的药物转运偶联至关重要。
Cell Mol Life Sci. 2016 May;73(9):1927-37. doi: 10.1007/s00018-015-2118-5. Epub 2015 Dec 26.
8
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.新型 BCR-ABL 和 FLT3 抑制剂 ponatinib 是一种有效的多药耐药相关三磷酸腺苷结合盒转运蛋白 ABCG2 的抑制剂。
Mol Cancer Ther. 2012 Sep;11(9):2033-44. doi: 10.1158/1535-7163.MCT-12-0302. Epub 2012 Jul 9.
9
The naphthoquinones, vitamin K3 and its structural analogue plumbagin, are substrates of the multidrug resistance linked ATP binding cassette drug transporter ABCG2.萘醌类、维生素K3及其结构类似物白花丹素是与多药耐药相关的ATP结合盒式药物转运蛋白ABCG2的底物。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3279-86. doi: 10.1158/1535-7163.MCT-07-0564. Epub 2007 Dec 7.
10
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.拉帕替尼(泰立沙,GW572016)通过抑制ATP结合盒亚家族B成员1和G成员2的活性来逆转癌细胞中的多药耐药性。
Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499.

引用本文的文献

1
How Cryo-EM Has Expanded Our Understanding of Membrane Transporters.冷冻电镜如何拓展我们对膜转运蛋白的理解。
Drug Metab Dispos. 2023 Aug;51(8):904-922. doi: 10.1124/dmd.122.001004. Epub 2023 Jul 12.
2
Nucleotide binding is the critical regulator of ABCG2 conformational transitions.核苷酸结合是 ABCG2 构象转变的关键调节剂。
Elife. 2023 Feb 10;12:e83976. doi: 10.7554/eLife.83976.
3
The first intracellular loop is essential for the catalytic cycle of the human ABCG2 multidrug resistance transporter.第一个细胞内环对于人 ABCG2 多药耐药转运蛋白的催化循环是必需的。
FEBS Lett. 2020 Dec;594(23):4059-4075. doi: 10.1002/1873-3468.13994. Epub 2020 Nov 21.
4
Picky ABCG5/G8 and promiscuous ABCG2 - a tale of fatty diets and drug toxicity.挑剔的 ABCG5/G8 和滥交的 ABCG2——高脂肪饮食和药物毒性的故事。
FEBS Lett. 2020 Dec;594(23):4035-4058. doi: 10.1002/1873-3468.13938. Epub 2020 Oct 14.
5
ABCG2 transports anticancer drugs via a closed-to-open switch.ABCG2 通过关闭到开放的开关转运抗癌药物。
Nat Commun. 2020 May 8;11(1):2264. doi: 10.1038/s41467-020-16155-2.
6
A single power stroke by ATP binding drives substrate translocation in a heterodimeric ABC transporter.ATP 结合驱动异构二聚体 ABC 转运蛋白的底物移位的单次动力冲程。
Elife. 2020 Apr 21;9:e55943. doi: 10.7554/eLife.55943.
7
Application of fluorescence correlation spectroscopy to study substrate binding in styrene maleic acid lipid copolymer encapsulated ABCG2.荧光相关光谱法在研究苯乙烯马来酸脂质共聚物包裹的 ABCG2 中底物结合的应用。
Biochim Biophys Acta Biomembr. 2020 Jun 1;1862(6):183218. doi: 10.1016/j.bbamem.2020.183218. Epub 2020 Feb 11.
8
3D structure of the transporter ABCG2-What's new?ABCG2 转运蛋白的三维结构——有何新发现?
Br J Pharmacol. 2020 Apr;177(7):1485-1496. doi: 10.1111/bph.14991. Epub 2020 Feb 11.
9
Disruption of the Unique ABCG-Family NBD:NBD Interface Impacts Both Drug Transport and ATP Hydrolysis.独特的 ABCG 家族 NBD:NBD 界面的破坏会同时影响药物转运和 ATP 水解。
Int J Mol Sci. 2020 Jan 23;21(3):759. doi: 10.3390/ijms21030759.
10
Conformational changes in a multidrug resistance ABC transporter DrrAB: Fluorescence-based approaches to study substrate binding.多药耐药 ABC 转运蛋白 DrrAB 的构象变化:基于荧光的研究底物结合的方法。
Arch Biochem Biophys. 2018 Nov 15;658:31-45. doi: 10.1016/j.abb.2018.09.017. Epub 2018 Sep 20.